Share This Post Wie können wir helfen? Suche Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanomaErstellt amOktober 4, 2017durchThomas Eigentler You are here: Knowledge Base Melanoma: Systemic treatment Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma < BackYou do not have access to this post. 1445534 {:LPR5HH3Z} 1 https://www.zotero.org/styles/urban-research-and-practice?source=1 50 default 1 1 145 http://www.hautkrebs-leitlinien.de/wp-content/plugins/zotpress/ Share This Post
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanomaErstellt amOktober 4, 2017durchThomas Eigentler You are here: Knowledge Base Melanoma: Systemic treatment Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma < BackYou do not have access to this post. 1445534 {:LPR5HH3Z} 1 https://www.zotero.org/styles/urban-research-and-practice?source=1 50 default 1 1 145 http://www.hautkrebs-leitlinien.de/wp-content/plugins/zotpress/